Capecitabine
MONC-HBP24
Phase 2 small_molecule completed
Quick answer
Capecitabine for Pancreatic Adenocarcinoma is a Phase 2 program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- Pancreatic Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed